Model 802 Gillian QA Phantom lo res

May 11, 2010 - Hybrid scanning systems are increasingly being used to improve tumor identification, treatment delivery and monitor treatment effectiveness.

Proper alignment of fused images is an ongoing concern, particularly with hybrid modalities, such as single photon emission computed tomography/computed tomography (SPECT/CT), positron emission tomography/computed tomography (PET/CT) and computed tomography/magnetic resonance imaging (CT/MRI).

The Model 802 Gillian QA Phantom recently released by CIRS Inc. is designed for evaluating image distortion and alignment in these hybrid scanning systems.

Images produced with the phantom can show if there is any mismatch in the fused images. The simple geometry allows for quick visual interpretation and independent assessment of equipment function.

This product is manufactured under license from King’s College Hospital NHS Foundation Trust.

For more information: www.cirsinc.com


Additional Content

News | FDA

Oct. 23, 2026 — Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta ...

Time November 06, 2026
arrow
News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
Subscribe Now